IN2015DN01331A - - Google Patents

Info

Publication number
IN2015DN01331A
IN2015DN01331A IN1331DEN2015A IN2015DN01331A IN 2015DN01331 A IN2015DN01331 A IN 2015DN01331A IN 1331DEN2015 A IN1331DEN2015 A IN 1331DEN2015A IN 2015DN01331 A IN2015DN01331 A IN 2015DN01331A
Authority
IN
India
Prior art keywords
trifluoromethylpyridin
morpholinyl
pyrimidinyl
intermediates
amine
Prior art date
Application number
Other languages
English (en)
Inventor
Dietmar Flubacher
Nicole Bieri
Murat Acemoglu
Pascal Michel
Rasmus Mose
Hans Stettler
Maria Caterina Testa
Jörg Brozio
Frank Schaefer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IN2015DN01331A publication Critical patent/IN2015DN01331A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IN1331DEN2015 2012-10-23 2013-10-21 IN2015DN01331A (enrdf_load_stackoverflow)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261717237P 2012-10-23 2012-10-23
US201361842101P 2013-07-02 2013-07-02
PCT/EP2013/071996 WO2014064058A1 (en) 2012-10-23 2013-10-21 Improved process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine

Publications (1)

Publication Number Publication Date
IN2015DN01331A true IN2015DN01331A (enrdf_load_stackoverflow) 2015-07-03

Family

ID=49448162

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1331DEN2015 IN2015DN01331A (enrdf_load_stackoverflow) 2012-10-23 2013-10-21

Country Status (15)

Country Link
US (1) US9637468B2 (enrdf_load_stackoverflow)
EP (1) EP2912030B1 (enrdf_load_stackoverflow)
JP (1) JP6267213B2 (enrdf_load_stackoverflow)
KR (1) KR102128127B1 (enrdf_load_stackoverflow)
CN (1) CN104736532B (enrdf_load_stackoverflow)
AU (2) AU2013336807B2 (enrdf_load_stackoverflow)
BR (1) BR112015007243B1 (enrdf_load_stackoverflow)
CA (1) CA2885471C (enrdf_load_stackoverflow)
ES (1) ES2605638T3 (enrdf_load_stackoverflow)
IN (1) IN2015DN01331A (enrdf_load_stackoverflow)
MX (1) MX360703B (enrdf_load_stackoverflow)
PL (1) PL2912030T3 (enrdf_load_stackoverflow)
PT (1) PT2912030T (enrdf_load_stackoverflow)
RU (1) RU2646760C2 (enrdf_load_stackoverflow)
WO (1) WO2014064058A1 (enrdf_load_stackoverflow)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103958506B (zh) 2011-09-27 2017-02-22 诺华股份有限公司 用作突变idh抑制剂的3‑嘧啶‑4‑基‑噁唑烷‑2‑酮化合物
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
US10173995B2 (en) * 2013-01-12 2019-01-08 Teligene Ltd. Pyridine compounds used as PI3 kinase inhibitors
AP2015008707A0 (en) 2013-03-14 2015-09-30 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
ES2713452T3 (es) 2014-04-22 2019-05-21 Univ Basel Proceso de fabricación para derivados de triazina, pirimidina y piridina
WO2016050201A1 (zh) * 2014-09-29 2016-04-07 山东轩竹医药科技有限公司 高选择性取代嘧啶类pi3k抑制剂
CN105085476B (zh) * 2014-11-24 2018-03-09 苏州晶云药物科技有限公司 5‑[2,6‑二(4‑吗啉基)‑4‑嘧啶基]‑4‑(三氟甲基)‑2‑吡啶胺二盐酸盐的晶型及其制备方法
CN105001151B (zh) * 2015-08-28 2017-07-14 苏州明锐医药科技有限公司 布帕尼西中间体及其制备方法
CN106543140A (zh) * 2015-09-21 2017-03-29 苏州晶云药物科技有限公司 5-[2,6-二(4-吗啉基)-4-嘧啶基]-4-(三氟甲基)-2-吡啶胺盐酸盐的晶型及其制备方法
CN107793394A (zh) * 2017-08-03 2018-03-13 上海厚璞生物科技有限公司 一种生产选择性pi3k抑制剂的系列关键中间体
CN118834204A (zh) * 2018-12-18 2024-10-25 阿斯利康(瑞典)有限公司 制药方法和中间体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062805A1 (fr) * 2001-02-08 2002-08-15 Toyama Chemical Co., Ltd. Derive d'acide 6-substitue alkylamino-3-pyridylborique ou d'un sel de celui-ci et leurs procedes de fabrication
ES2375111T3 (es) * 2002-11-21 2012-02-24 Novartis Ag Pirimidinas 2,4,6-trisustituidas como inhibidores de fosfotidilinositol (pi) 3-quinasa y su uso en el tratamiento de c�?ncer.
JO2660B1 (en) * 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
RU2576619C2 (ru) * 2010-10-01 2016-03-10 Новартис Аг Способ получения пиримидиновых производных

Also Published As

Publication number Publication date
KR20150072408A (ko) 2015-06-29
RU2646760C2 (ru) 2018-03-07
JP2016502510A (ja) 2016-01-28
CN104736532A (zh) 2015-06-24
KR102128127B1 (ko) 2020-06-30
US9637468B2 (en) 2017-05-02
BR112015007243B1 (pt) 2022-02-08
US20150246897A1 (en) 2015-09-03
EP2912030A1 (en) 2015-09-02
CA2885471A1 (en) 2014-05-01
PT2912030T (pt) 2016-11-30
ES2605638T3 (es) 2017-03-15
AU2013336807B2 (en) 2016-10-27
CN104736532B (zh) 2017-04-05
WO2014064058A1 (en) 2014-05-01
EP2912030B1 (en) 2016-08-31
BR112015007243A2 (pt) 2017-07-04
CA2885471C (en) 2021-02-23
MX2015005188A (es) 2015-09-07
MX360703B (es) 2018-11-14
RU2015119259A (ru) 2016-12-20
PL2912030T3 (pl) 2017-02-28
AU2013336807A1 (en) 2015-03-05
AU2016238941A1 (en) 2016-11-03
JP6267213B2 (ja) 2018-01-24

Similar Documents

Publication Publication Date Title
IN2015DN01331A (enrdf_load_stackoverflow)
LT3577110T (lt) 8-oksetan-3-il-3,8-diazabiciklo[3.2.1]oktan-3-ilo pakeistieji junginiai, kaip živ inhibitoriai
MY171055A (en) 3,5-disubstituted alkynylbenzene compound and salt thereof
SG11201912770SA (en) a, ß-UNSATURATED AMIDE COMPOUND
MY163187A (en) Novel imidazo-oxazine compound or salt thereof
MX2015002040A (es) Baricitinib deuterado.
IN2014DN06812A (enrdf_load_stackoverflow)
IN2015DN00598A (enrdf_load_stackoverflow)
BR112015001201A2 (pt) compostos anti-infecciosos 5,5-heteroaromáticos.
PT3418275T (pt) Composto inovador de tiofeno substituído em 2,3,5 como inibidor de proteína quinase
MX366983B (es) Derivados de 1,5-naftiridina e inhibidores de cinasa de cremallallera de leucina embrionica materna que los contienen.
EP3083555A4 (en) Processes for the diazotization of 2,5-dichloroanilines
IL231468A0 (en) 3,1-diaryl-converted heterocyclic pesticides
MX2015008829A (es) Momelotinib deuterado.
IL251500A (en) A new compound containing nitrogen or its salt or metallic complex
MY166058A (en) Method for preparation of medetomidine
HK1224305A1 (zh) 用於治療重度低血糖症的新型化合物
WO2014105777A8 (en) Cobicostat dichlohydrate salt
WO2014064714A3 (en) Process for preparation of lurasidone hydrochloride
MX2015012610A (es) Pacritinib deuterizado.
IT1402456B1 (it) Macchina per realizzare gabbie metalliche.
MY174415A (en) Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof
PL3153022T3 (pl) N-(3’,4’-dichloro-5-metoksybifenyl-2-ylo)-3-(difluorometylo)-1-metylo-1H-pirazolo-4-karboksyamid
UA88965U (uk) Сполука 1,3-біс-(2-гидроксіетил)-урацил, що має інотропну активність
UA83239U (uk) 2-(4,5-дифеніл-4h-[1,2,4]триазол-3-їлсульфаніл)-n-арилацетаміди, що мають протипухлинну активність